Lure Of Niche Drugs Lead India's Cadila To Buy Troubled KV Pharma's Generic Arm For $60 Million

MUMBAI - Troubled U.S. drug maker KV Pharmaceutical Co. met what it called "an important goal" managing to sell its generic drugs subsidiary Nesher Pharmaceuticals Inc. to one of India's fastest-growing generic drug makers Cadila Healthcare Ltd. Cadila's U.S. arm Zydus Pharmaceuticals Inc. facilitated its first buyout in the U.S. through its subsidiary Zynesher Pharmaceuticals USA LLC